Terumo Corp.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Total-Other-Finance-Cost" stands at -6.18 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025.
Terumo Corp.'s second quarter result of -0.018 Billion JPY for the item "Total Other Finance Cost" represents an increase of 98.59 percent compared to it's first quarter result.
Also, Terumo Corp.'s second quarter result of -0.018 Billion JPY for the item "Total Other Finance Cost" represents an increase of 99.50 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Terumo Corp.'s second quarter result of -6.18 Billion JPY for the item "Total Other Finance Cost" represents an increase of 36.90 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -1.98 Billion Japanese Yens compared to the value the year prior.
The 1 year change is -1.98 Billion Japanese Yens.
The 3 year change is -5.92 Billion Japanese Yens.
The 10 year change is -4.83 Billion Japanese Yens.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Abbott Laboratories - Total Other Finance Cost | 217,696,616,448.00 |
![]() | Intuitive Surgical Inc - Total Other Finance Cost | 206,245,888,000.00 |
![]() | EssilorLuxottica S. A. - Total Other Finance Cost | 172,241,486,586.05 |
![]() | Danaher Corporation - Total Other Finance Cost | 162,006,663,168.00 |
![]() | Boston Scientific Corp - Total Other Finance Cost | 144,567,730,176.00 |